Rhythm Pharmaceuticals
RYTM
RYTM
126 hedge funds and large institutions have $1.08B invested in Rhythm Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 46 increasing their positions, 24 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.27% less ownership
Funds ownership: 110.59% → 106.32% (-4.3%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
41% less capital invested
Capital invested by funds: $1.81B → $1.08B (-$734M)
Holders
126
Holding in Top 10
4
Calls
$12.9M
Puts
$3.25M
Top Buyers
| 1 | +$12.4M | |
| 2 | +$9M | |
| 3 | +$8.92M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$5.25M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$4.83M |
Top Sellers
| 1 | -$43M | |
| 2 | -$35.7M | |
| 3 | -$10.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.73M |
| 5 |
ACM
Altium Capital Management
New York
|
-$4.95M |